Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Table 2 Main characteristics of operated patients

Patient no.	Gender	Age (years)	P/R	Number of lesions (single/multiple)	Lesion location	Preoperative TKIs duration (months)	Surgical procedure	Margin status
1	M	57	P	Single	Stomach	18	Partial gastrectomy combined with spleen resection	R0
2	M	44	P	Single	Small bowel	19	Partial small bowel resection	R0
3	M	39	R	Multiple	Small bowel and omentum	9	Tumor resection combined with partial small bowel resection	R0
4	M	41	R	Multiple	Small bowel and liver	6	Partial small bowel resection combined with liver RFA	R2
5	M	63	R	Multiple	Omentum and mesentery of small bowel	18	Tumor resection	R0
6	M	46	P	Single	Rectum	6	Abdominoperineal resection	R0
7	M	35	P	Single	Colon	13	Partial colon resection	R0
8	F	52	P	Single	Rectum	5	Abdominoperineal resection	R0
9	M	37	R	Single	Rectum	12	Abdominoperineal resection	R0
10	M	28	R	Multiple	Colon and small bowel	36	Partial colon and small bowel resection	R0
11	F	60	P	Single	Small bowel	12	Partial small bowel resection	R0
12	F	61	P	Single	Rectum	12	Sphincter-sparing resection by laparoscope	R0
13	M	51	P	Single	Rectum	24	Sphincter-sparing resection	R0
14	M	57	P	Single	Small bowel	8	Partial small bowel resection	R0
15	M	44	R	Single	Rectum	36	Sphincter-sparing resection	R0
16	F	59	P	Single	Rectum	10	Sphincter-sparing resection	R0
17	F	55	P	Single	Stomach	13	Partial gastrectomy	R0
18	F	53	P	Single	Stomach	9	Partial gastrectomy	R0
19	M	43	P	Single	Stomach	12	Partial gastrectomy	R0

M male, F female, P/R primary/recurrent or metastatic, RFA radiofrequency ablation

ISSN: 1477-7819